$Nuburu(BURU.US$ $Nuburu gut feeling is telling me relist Before r/s. (I am not sure) If they have to be at dollar before The relist but I am thinking they will not have to be so we might get a week half or few days relist before r/s. Will be very beneficial to get price higher before r/s and relist before r/s will do it
3
GuruMeister
voted
Morning traders! Happy Friday, June 28th. Investors are reacting to the Trump Biden debate, which to me, felt like two old men were angry at bingo night at the old folks home.
My name is Kevin Travers; here are stories from the moomoo herd on Wall Street today.
$Nike(NKE.US$ fell 15% after reporting earnings Thursday, meeting EPS expectations but announcing weak guidance for the coming quarter...
My name is Kevin Travers; here are stories from the moomoo herd on Wall Street today.
$Nike(NKE.US$ fell 15% after reporting earnings Thursday, meeting EPS expectations but announcing weak guidance for the coming quarter...
29
28
$Nuburu(BURU.US$ why does it say -97%
2
GuruMeister
liked
$Nuburu(BURU.US$ news they paid off debt thats good now halt pending news. hope a merger
2
10
GuruMeister
liked
4
2
GuruMeister
liked
$Seelos Therapeutics(SEEL.US$ Seelos Therapeutics Announces Strategic Focus on Mental Health Initiatives and Provides an Update on Current Discussions of Potential Partnerships and Collaborations
3
GuruMeister
reacted to
Cannabis stocks advanced on Monday after Vice President Kamala Harris convened a roundtable discussion about marijuana reform at the White House last Friday. Canopy Growth rose more than 20% and Aurora Cannabis jumped 15.21%.
Harris stated during the meeting that the current scheduling of marijuana as a Schedule I drug alongside heroin is "absurd" and "patently unfair." The Biden administration has initiated efforts to resche...
Harris stated during the meeting that the current scheduling of marijuana as a Schedule I drug alongside heroin is "absurd" and "patently unfair." The Biden administration has initiated efforts to resche...
26
4
GuruMeister
liked
$Seelos Therapeutics(SEEL.US$ Seelos Therapeutics Filed U.S. Patent Application #20240009113 : Treatment Of Protein Aggregation Myopathic And Neurodegenerative Diseases By Parenteral Administration Of Trehalose
3